CARSON CITY, NV / ACCESSWIRE / February 24, 2017 / Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that it has retained Think Ink Marketing Data & Email Services, Inc. (“Think Ink”) to develop an investor outreach program. The Company agreed to pay Think Ink a one-time fee of $75,000 for the first month of their services.

Think Ink Marketing Data & Email Services, Inc. is a California-based marketing firm, established in 2013, that provides its customers with a complete range of marketing services that span both digital and direct mail venues. With its digital services ranging from data appending, email marketing, and pay-per-click online banner and native ads, the company helps its clients to reach a large network of potential investors.

About Cell MedX Corp.

Cell MedX Corp. is an early development stage bio-tech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions, including, but not limited to, diabetes, Parkinson’s disease, and high blood pressure. For more information about the Company and its technology, please visit our website at: www.cellmedx.com. For the Company’s newsletter, please go to www.cellmedx.com/media/newsletters/.

On behalf of the Board of Directors of Cell MedX Corp.

Frank McEnulty
Chief Executive Officer and President.

Forward-Looking Statements

The information included in this press release has not been reviewed by the FDA, nor has it been peer reviewed. This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and assumptions and are identified by words such as “expects,” “intends,” “estimates,” “projects,” “anticipates,” “believes,” “could,” and other similar words. All statements addressing product performance, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in the Company’s Quarterly, Annual, and Current Reports filed with the United States Securities and Exchange Commission (the “SEC”). Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Company’s forward-looking statements. In particular, the Company’s eBalance technology is still in development. Except as required by law, Cell MedX Corp. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that Cell MedX Corp. files from time to time with the SEC, including its Annual, Quarterly, and Current Reports.

For further information, visit: www.cellmedx.com
Or phone: 1-844-238-2692

SOURCE: Cell MedX Corp.

ReleaseID: 455963

RENO, NV / ACCESSWIRE / February 24, 2017 / Renaissance Gold Inc. (TSX-V: REN) (“RenGold” or the “Company”) reports its operational and financial results for the six months ended December 31, 2016.

Details of the Company’s financial results are described in the unaudited condensed consolidated interim financial statements for the six months ended December 31, 2016 and corresponding management discussion and analysis – quarterly highlights for the same period. These, and further details on each of RenGold’s projects and activities, can be found on the Company’s website at www.rengold.com and on the Company’s profile on www.sedar.com.

Operations:

Activity in the second fiscal quarter ended December 31, 2016 and up to the date of this release resulted in the following announcements:

October 31, 2016 – RenGold announced encouraging channel sample results at its Buffalo Canyon, Nevada project
January 11, 2017 – RenGold announced that generative efforts resulted in the staking of two new Carlin-style projects in North East Nevada being the Diamond Point project and the Spruce East projects
February 9, 2017 – RenGold announced the signing of a non-binding letter of intent to form a strategic alliance with Coeur Mining, Inc. to fund grass roots exploration in a defined area of Nevada subject to definitive documentation
February 20, 2017 – RenGold announced the signing of a non-binding letter of intent with Kinross Gold U.S.A., Inc. to form an earn-in agreement on the Buffalo Canyon, Diamond Point and Spruce East projects and to subscribe for no less than 5% and not more than 9.9% of the common shares of RenGold at a price of C$0.33 all subject to definitive documentation.

Ron Parratt, President and CEO, states, “RenGold has a total of 6 of its 15 projects in earn-in agreements with industry partners. It is anticipated that at least three projects will see some drilling this year and, based on outcomes, aggressive follow-up may be warranted.”

Financial:

Cash at December 31, 2016 was $1,299,514, including $115,388 of cash advances received from funding partners which must be expended on the projects under agreements.

Exploration and evaluation expenditures on RenGold projects for the six months ended December 31, 2016, totaled $687,366 down from $1,157,250 in the comparative six month period. Of this amount, partners funded $286,802 (2015 – $820,429) and RenGold funded the balance of $400,564 (2015 – $336,821).

General and administrative expenses, adjusted for foreign exchange and non-cash items, totalled $446,873 for the six months ended December 31, 2016 compared to $343,612 in the comparative six month period. When added to total exploration and evaluation expenditures, this represents only 39% (2015 – 23%) of total expenditures.

The consolidated net loss for the six months ended December 31, 2016 was $976,638 compared to $709,127 in the prior six month period.

About Renaissance Gold Inc.

Renaissance Gold Inc. is a gold/silver exploration company that has a large portfolio of exploration projects in Nevada and Utah. RenGold’s objective is to place the projects in exploration earn-in agreements with industry partners who provide exploration funding. RenGold applies the extensive exploration experience and high-end technical skills of its founders and team members to search for and acquire new precious metal exploration projects that are then offered for joint venture.

Renaissance Gold Inc.

By: Ronald Parratt, President and CEO
For further information, contact:
Ronald Parratt, 775-337-1545 or rparratt@rengold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains certain statements that may be deemed “forward-looking” statements. forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or that events or conditions “will,” “would,” “may,” “could” or “should” occur. Although Renaissance Gold Inc. believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward-looking statements. forward-looking statements are based on the beliefs, estimates and opinions of Renaissance Gold Inc’s management on the date the statements are made. Except as required by law, Renaissance Gold Inc. undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.

SOURCE: Renaissance Gold Inc.

ReleaseID: 455947

TORONTO, ON / ACCESSWIRE / February 24, 2017 / An intricate web of regulations, strategies, and fears tying emerging markets to oil production presents interesting opportunities for investors according to Konstantinos Kazinakis, President and COO of United Bunkers Investors Corporation in Toronto. Overseeing 21 years of investment transactions with value approaching $1.5 billion USD, Kazinakis has shared his insights on commodity trading and the future of developing economies as seen from their potential for oil production.

While optimists believe in the strong correlation between high-yield bonds and crude futures and petrol, suggesting that low interest should boost emerging countries, Kazinakis is convinced that short interest on the liquid oil shares is not always an indicator of economic performance and warns investors to be mindful of the consequences of price drops that might be quite detrimental for the bonds industry. Governments are also responding to the steady drop in oil prices, especially as OPEC has refused to freeze crude production, which has been offered as a solution to stabilize the global market. Saudi Arabia, the world’s largest exporter of oil, along with other member countries within the cartel, acknowledge the price volatility that stroke the energy industry, but have remained reluctant to restrain the production. On the bright side, the excess in petroleum and other liquid fuels supply has been reduced by a slowdown that occurred in the non-OPEC countries, particularly in Canada and Nigeria – a solution that appeared very timely since it helped to slightly stimulate energy prices.

Konstantinos Kazinakis forecasts a steady growth for consumer countries across Europe, Asia, and South America. The dipping commodity prices serve as a great stimulus for oil and gas importing nations in the European continent, and are certainly a good opportunity for newly industrialized markets, such as Japan, China, and India, to boost their fiscal resilience against capital outflows. In the current context of very complex energy paradigm, the biggest winners are companies based in the rapidly growing economies of Asian and Latin American countries. Brazilian oil and gas operator Braskem S.A., for instance, saw a remarkable growth in revenues by 100% in 2013 and 2014. China’s Sinopec, the largest oil refiner and producer of oil and gas in the country, has immense advantages for further solidifying its positions in view of the global energy developments of the past years, mainly due to its colossal deposits of fuel and energy resources, unprecedented government support, and unlimited domestic demand. While uncertainties remain, the current geopolitical and economic outlook is more optimistic than it was two years ago, offering new avenues for growth and forecasting notably improved outcomes, particularly to developing countries in the BRICS geopolitical alliance led by Russia, Iran, Brazil, China, and some parts of Africa.

Konstantinos Kazinakis is the President and COO of the Toronto-based United Bunkers Investors Corporation. A renowned investor with over 20 years of experience in managing trade financing domestically and internationally, he has in-depth knowledge in debt restructuring and equity investments. To date, Kazinakis’ portfolio includes transactions of over $1.5 billion and successful repositioning of $1 billion of non-performance loans. Building from his interest in oil and gas sector and shipping industry, he provides innovative solutions for commodity trading, offering comprehensive financial and logistic support to the energy companies, oil cargo and bunkering traders, refineries, and producers. United Bunkers Investors Corporation is supported by Financial Technology trade financing platform for a high technology solution to the global trade finance market, which is worth more than $ 4 Trillion US dollars a year, the gap is currently around $1.4 Trillion for the innovation in making trade financing more efficient and to protect against all risk.

Konstantinos Kazinakis – United Bunkers Investors Corporation: http://KonstantinosKazinakisNews.com

Konstantinos Kazinakis of United Bunkers Investors Corporation Evaluates the Benefits of Global Trade Financing: http://finance.yahoo.com/news/konstantinos-kazinakis-united-bunkers-investors-034900501.html

Konstantinos Kazinakis of United Bunkers Investors Corporation Evaluates the Benefits of Global Trade Financing: http://finance.yahoo.com/news/konstantinos-kazinakis-united-bunkers-investors-034900501.html

Contact Information

KonstantinosKazinakisNews.com
www.KonstantinosKazinakisNews.com
contact@konstantinoskazinakisnews.com

SOURCE: United Bunkers Investors Corporation

ReleaseID: 455960

IRVINE, CA / ACCESSWIRE / February 24, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Inotek Pharmaceuticals Corporation (“Inotek” or the “Company”) (NASDAQ: ITEK). Investors, who purchased or otherwise acquired shares between July 23, 2015 and December 30, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the March 7, 2017 lead plaintiff motion deadline.

If you purchased shares of Inotek during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The Complaint states that on July 23, 2015, Inotek disclosed a successful End of Phase 2, mentioning that the Company is in the “final preparation stages to begin its first Phase 3 trial in 4Q and look forward to data in 2016.” Inotek predicted a successful end for the Phase 3 trabodenoson trial, causing the company’s share price to inflate greatly to $15.37 per share on July 23, 2015. Inotek’s Form 10-K filing also suggested to investors that trabodenoson would be successful, as it holds an impressive safety record contrasted to similar glaucoma treatments.

However, the Complaint maintains that Inotek officials were told a section of the clinical trial of trabodenoson would not meet its primary objective of decreasing intraocular pressure compared with the placebo. Inotek revealed on January 3, 2017 that the initial pivotal Phase 3 trial of trabodenoson to treat open-angle glaucoma or ocular hypertension failed, in comparison to the placebo, in its primary objective of superiority in the reduction of intraocular pressure.

When this information was revealed to the public, the value of Inotek stock dropped, causing investors harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 455956

LAS VEGAS, NV / ACCESSWIRE / February 24, 2017 / Virginia Beach, Virginia, is situated where the Chesapeake Bay meets the Atlantic Ocean, site of the 1607 Jamestown landing marking the arrival of America’s first English colonists. The three-mile long boardwalk is recognized by the Guinness Book of World Records as the “longest pleasure beach in the world” – which happens to be at the southern end of the Chesapeake Bay Bridge Tunnel, also officially the world’s longest bridge-tunnel. Of course, water sports are a mainstay with jet skiing, parasailing, and even kiteboarding, all along the oceanfront.

A few iconic activities include hiking False Cape, visiting First Landing, or touring the Back Bay National Wildlife Refuge. The area hosts a long list of festivals, marathons, and other events annually, including the East Coast Surfing Championships, as well as the North American Sand Soccer Championship, a beach soccer tournament. Diamond Resorts International®, a global leader in the vacation ownership industry with over 370 managed and affiliated properties and cruise itineraries, manages two excellent vacation destinations in Virginia Beach – Beach Quarters Resort and Oceanaire Resort. To help visitors understand the highlights and differences of each, Diamond Resorts Reviews has taken a closer look at them.

Diamond Resorts Reviews considers Beach Quarters Resort to be a high-value vacation hotspot, with the most amenities of any other resort on the beach, while also offering an excellent value for the price. It boasts rooftop tennis, shuffleboard, and a swimming pool, as well as a second indoor pool and hot tub with stunning oceanfront views. The understated, airy, stylish rooms (studios, one- and two-bedrooms) all have oceanfront balconies, flat-screen TVs, and free Wi-Fi, along with well-equipped kitchenettes, microwaves, and mini-fridges. Some suites include full kitchens and whirlpool tubs. Additional on-site recreational facilities include a game room, gym, and sauna.

The guest experience at Oceanaire Resort is unparalleled for Virginia Beach, with a more deluxe atmosphere, in addition to being situated in the middle of the beach strip, allowing easy access to everything. The property boasts four beachfront pools – two indoor and two outdoor – as well as an ocean-view fitness center and valet parking. Accommodations range from a studio up to a three-bedroom penthouse suite. All of the rooms are decorated with plush bedding, triple sheeting, deep jet tubs, as well as stainless steel appliances and granite countertops in the partially- and fully-equipped kitchens. Additional standard amenities include flat-screen TVs with Blu-Ray players, safes, and private balconies. Diamond Resorts Reviews’ experts love the range of choices of on-site dining opportunities for all moods and guest personalities – whether it’s a casual restaurant, fun tiki bar, or a sophisticated martini lounge, every guest can find something to satisfy their taste.

About Diamond Resorts International®

Diamond Resorts International®, with its network of more than 370 vacation destinations located in 35 countries throughout the continental United States, Hawaii, Canada, Mexico, the Caribbean, South America, Central America, Europe, Asia, Australasia, and Africa, provides guests with choice and flexibility to let them create their dream vacation, whether they are traveling an hour away or around the world. Our relaxing vacations have the power to give guests an increased sense of happiness and satisfaction in their lives, while feeling healthier and more fulfilled in their relationships, by enjoying memorable and meaningful experiences that let them Stay Vacationed.TM

Diamond Resorts International® manages vacation ownership resorts and sells vacation ownership points that provide members and owners with Vacations for Life® at over 370 managed and affiliated properties and cruise itineraries.

Diamond Resorts Reviews – Diamond Resorts International®: http://diamondresorts-reviews.com

Diamond Resorts International® Timeshare Reviews: http://diamondresortstimesharereviews.com

Diamond Resorts (@diamondresorts) – Twitter: https://twitter.com/diamondresorts

Diamond Resorts International® Why Vacations for Life® – YouTube: https://www.youtube.com/watch?v=wuBW2aWUO5s

For more information: www.diamondresorts.com

Contact Information

Angela Triano
Tel: 551-574-8332
trianoangela@yahoo.com

SOURCE: Diamond Resorts International

ReleaseID: 455955

NEW YORK, NY / ACCESSWIRE / February 24, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Inotek Pharmaceuticals Corporation (“Inotek” or the “Company”) (NASDAQ: ITEK) of the March 7, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of all those who purchased Inotek common stock between July 23, 2015 and December 30, 2016 (the “Class Period”). The case, Whitehead
v. Inotek Pharmaceuticals Corporation et al, No. 1:17-cv-10025, was filed on January 6, 2017.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by misrepresenting the efficacy of its lead drug candidate for glaucoma and the only product it is currently developing in its pipeline, trabodenoson; and its attendant capacity to receive New Drug Approval by the U.S. Food and Drug Administration. Specifically, the lawsuit alleges that Inotek made positive statements about trabodenoson despite knowledge that the MATrX-1 phase 3 clinical trial would fail to meet its primary endpoint.

Then, pre-market on January 3, 2017, Inotek issued a
press release announcing that the first pivotal Phase 3 trial of trabodenoson
failed to reach its primary endpoint of superiority in the reduction of
intraocular pressure compared with placebo at all twelve (12) time points.

After the announcement, Inotek’s share price fell from $6.10 per share on December 30, 2016 to a closing price of $1.75 on January 3, 2017 – a $4.35 or a 71.31% drop.

Request more information now by clicking
here: www.faruqilaw.com/ITEK
. There is no cost or obligation to you.

Take Action

If you invested in Inotek stock or options between July 23, 2015 and December 30, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/ITEK. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330, or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Inotek’s conduct to contact the firm, including whistleblowers, former employees, shareholders, and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP

685 Third Avenue, 26th Floor

New York, NY 10017

Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 455949

BALA CYNWYD, PA / ACCESSWIRE / February 24, 2017 / Law office of Brodsky & Smith, LLC announces class action lawsuits have been filed in the U.S. District Court for the Eastern District of Wisconsin against Roadrunner Transportation Systems, Inc. (NYSE: RRTS) (“Roadrunner” or the “Company”) on behalf of purchasers of the Company’s securities between May 8, 2014 and January 30, 2017, inclusive (the “Class Period”).

Click here to learn more: http://www.brodskysmith.com/cases/roadrunner-transportation-systems-inc-nyse-rrts/, or call: 877-534-2590. There is no cost or obligation to you.

The class action cases allege that the Company and its executives violated federal securities laws by failing to maintain proper accounting procedures, which came to light on January 30, 2017. The errors include unrecorded expenses from unreconciled balance sheet accounts, including cash, driver and other receivables, and linehaul and other driver payables. The Company anticipates prior period adjustments to results of operations of between $20 million and $25 million. On this news, shares of the Company’s stock fell $3.62 per share, or over 31%, to close on January 31, 2017 at $7.92.

If you own shares of Roadrunner Transportation Systems stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/roadrunner-transportation-systems-inc-nyse-rrts/, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

ReleaseID: 455954